# Analytical Services Center for Medications Development Program

Canonical: https://abierto.us/opportunities/75n98026d00031

- Solicitation number: 75N98026D00031
- Notice type: Award notice
- Status: Awarded to MRIGLOBAL Kansas City for $5,000,000.00
- Department: Department of Health and Human Services
- Agency: National Institutes of Health
- Contracting office: National Institutes of Health Nida (75N950)
- NAICS: 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Product or service code: AN11 Health R&D Services; Health Care Services; Basic Research
- Place of performance: Bethesda, Maryland
- First posted: July 17, 2026
- Last posted: July 17, 2026
- SAM.gov: https://sam.gov/workspace/contract/opp/3f6ba6366b7149e697544a1a11cddfb6/view

## Description

NOTICE OF AWARD. THIS IS NOT A REQUEST FOR QUOTE/PROPOSALS. On July 17, 2022; in response to the requirements of Solicitation 75N95024R00032, the National Institute on Drug Abuse (NIDA) awarded Contract No. 75N98026D00031 to MRIGlobal for the Analytical Services Center for Medications Development . NIDA anticipates the use of Task Orders with an ultimate Period of Performance of five (5) years. An award shall be made on a Cost Plus Fixed Fee and Firm Fixed Price basis.

## Publications

- July 17, 2026: Award notice. Notice 3f6ba6366b7149e697544a1a11cddfb6. https://sam.gov/workspace/contract/opp/3f6ba6366b7149e697544a1a11cddfb6/view

## Points of contact

- Shaun Rostad, shaun.rostad@nih.gov, 3015949516
- Josh Lazarus, josh.lazarus@nih.gov, 3018276923

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/75n98026d00031.